Eupnea, founded in 2017 and headquartered in Norway, is positioned at the intersection of Health Care, Medical Devices, and Autonomous and Sensor Tech. Their mission revolves around innovating respiratory monitoring technologies, emphasizing their slogan, "Intelligent respirator monitoringEvery breath counts".
The company's core focus is on developing a cost-effective sensor capable of continuously and accurately measuring respiratory frequency (RF), a critical vital sign often relegated to manual monitoring by healthcare staff. By automating this process, Eupnea strives to provide early detection and intervention capabilities for severe illnesses, enhancing patient care.
Currently, Eupnea has not disclosed any last investment figures or investor details, which could present a fresh opportunity for investors seeking an entry point into innovative health tech solutions, particularly those that leverage autonomous and sensor technologies for better patient outcomes.